Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05354505 · ClinicalTrials.gov registry record · NA
Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)
A NA study of Diaphragmatic Hernia, sponsored by Vincent Duron.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05354505 is a NA study of Diaphragmatic Hernia that is actively recruiting participants, run by Vincent Duron. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05354505, a NA study of Diaphragmatic Hernia, is actively recruiting participants, sponsored by Vincent Duron.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single site, single arm, non-randomized, pilot trial to assess the feasibility and safety of treating severe congenital diaphragmatic hernia (CDH) with Fetal Endoscopic Tracheal Occlusion (FETO) at Columbia University Irving Medical Center (CUIMC)/ NewYork-Presbyterian Hospital (NYP).
Conditions Studied
Interventions
- DEVICE Placement of the GOLDBAL2 balloon
Study Locations (1)
New York
- Columbia University Irving Medical Center/NewYork-Presbyterian - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-01 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05354505
The ClinicalTrials.gov registry entry for NCT05354505 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vincent Duron, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diaphragmatic Hernia appearing as the primary indexed condition, and to 1 intervention - of which Placement of the GOLDBAL2 balloon is the first listed.
NCT05354505 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05354505 about?
NCT05354505 is a clinical study titled "Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)". This is a single site, single arm, non-randomized, pilot trial to assess the feasibility and safety of treating severe congenital diaphragmatic hernia (CDH) with Fetal Endoscopic Tracheal Occlusion (FETO) at Columbia University Irving Medical Center (CUIMC)/ NewYork-Presbyterian Hospital (NYP).
What is the current status of trial NCT05354505?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-01. Estimated completion is 2028-06.
What conditions does trial NCT05354505 study?
This clinical trial studies the following conditions: Diaphragmatic Hernia.
What interventions are being tested in trial NCT05354505?
The interventions under investigation include: Placement of the GOLDBAL2 balloon (DEVICE).
Who is sponsoring clinical trial NCT05354505?
This trial is sponsored by Vincent Duron, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05354505 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.